Smart MOF-integrated biopolymeric hydrogel systems as a novel strategy for sustained anticancer drug delivery

Key Points

• Sustained drug delivery from biopolymeric hydrogel systems boosts therapeutic efficacy against cancer.
• In vitro studies demonstrated a notable increase in drug release at targeted sites compared to controls.
• Analysis utilized an integrated MOF framework within the hydrogel, tailoring drug release profiles for maximum impact.
• This novel delivery approach may enhance treatment outcomes; clinical studies are necessary to validate efficacy.